These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 29424765)

  • 41. Effective Treatment of Xanthelasma.
    Sansalone K; Beer K; Pavlis J
    J Drugs Dermatol; 2016 Jul; 15(7):891-2. PubMed ID: 27391641
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Xanthelasma palpebrarum removed with Atmospheric Plasma technique: 11-year follow up.
    Scarano A; Inchingolo F; Scogna G; Leo L; Crisante A; Greco Lucchina A; Lorusso F
    J Biol Regul Homeost Agents; 2021; 35(2 Suppl. 1):181-185. PubMed ID: 34281315
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Treatment of xanthelasma palpebrarum with a 1064-nm, Q-switched Nd:YAG laser.
    Heng JK; Chua SH; Goh CL; Cheng S; Tan V; Tan WP
    J Am Acad Dermatol; 2017 Oct; 77(4):728-734. PubMed ID: 28666611
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Xanthelasma palpebrarum and dyslipoproteinaemia: two retrospective studies (author's transl)].
    Rouffy J; Chanu B; Bakir R; Goy-Loeper J; Bouthillier D; Goussault Y; Dreux C
    Ann Dermatol Venereol; 1982; 109(3):231-5. PubMed ID: 7114736
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Xanthelasma-Like Reaction to Filler Injection.
    Or L; Eviatar JA; Massry GG; Bernardini FP; Hartstein ME
    Ophthalmic Plast Reconstr Surg; 2017; 33(4):244-247. PubMed ID: 27218809
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Laser treatment of giant xanthelasma palpebrarum.
    Corradino B; Di Lorenzo S; Triolo A; Moschella F
    Lasers Med Sci; 2015 Nov; 30(8):2205-7. PubMed ID: 25252796
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Xanthelasma palpebrarum: a marker of premature atherosclerosis (risk of atherosclerosis in xanthelasma).
    Pandhi D; Gupta P; Singal A; Tondon A; Sharma S; Madhu SV
    Postgrad Med J; 2012 Apr; 88(1038):198-204. PubMed ID: 22362903
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Treatment of Xanthelasma Palpebrarum With Intralesional Pingyangmycin.
    Wang H; Shi Y; Guan H; Liu C; Zhang W; Zhang Y; Liu A; Qian Y; Zhao Y; Jiang H
    Dermatol Surg; 2016 Mar; 42(3):368-76. PubMed ID: 26890801
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Inflammatory Mediators in Xanthelasma Palpebrarum: Histopathologic and Immunohistochemical Study.
    Govorkova MS; Milman T; Ying GS; Pan W; Silkiss RZ
    Ophthalmic Plast Reconstr Surg; 2018; 34(3):225-230. PubMed ID: 28481769
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Cardiovascular profile of xanthelasma palpebrarum.
    Dey A; Aggarwal R; Dwivedi S
    Biomed Res Int; 2013; 2013():932863. PubMed ID: 23865074
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Bilateral tumor-like invasive xanthelasma palapebrarum in the superior palpebra.
    Ohta M; Suzuki Y; Sawada M
    Ophthalmic Plast Reconstr Surg; 1996 Sep; 12(3):196-8. PubMed ID: 8869976
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Assessment of efficacy and tolerability of different concentrations of trichloroacetic acid vs. carbon dioxide laser in treatment of xanthelasma palpebrarum.
    Mourad B; Elgarhy LH; Ellakkawy HA; Elmahdy N
    J Cosmet Dermatol; 2015 Sep; 14(3):209-15. PubMed ID: 26251333
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Lipid metabolism and apolipoprotein E phenotypes in patients with xanthelasma.
    Ribera M; Pintó X; Argimon JM; Fiol C; Pujol R; Ferrándiz C
    Am J Med; 1995 Nov; 99(5):485-90. PubMed ID: 7485205
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Unilateral xanthelasma forming a kissing-like lesion.
    Bak H; Park SG; Jeon SY; Choi EH; Ahn SK
    J Dermatol; 2005 Mar; 32(3):220-2. PubMed ID: 15863872
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Clinical association between serum cholesterol level and the size of xanthelasma palpebrarum.
    Kim YG; Oh JW; Lee KC; Yoon SH
    Arch Craniofac Surg; 2022 Apr; 23(2):71-76. PubMed ID: 35526842
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Treatment of Grade I and II types of xanthelasma palpebrarum with intralesional heparin sodium.
    Ren J; Zeng LY; Chen MH
    Dermatol Ther; 2018 Nov; 31(6):e12723. PubMed ID: 30358038
    [No Abstract]   [Full Text] [Related]  

  • 57. Bilateral extensive xanthelasma palpebrarum.
    Tosti A; Varotti C; Tosti G; Giovannini A
    Cutis; 1988 Feb; 41(2):113-4. PubMed ID: 3345685
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Xanthelasma palpebrarum].
    Kemler MA; Deenstra W; Kon M
    Ned Tijdschr Geneeskd; 1996 May; 140(19):1014-7. PubMed ID: 8684493
    [No Abstract]   [Full Text] [Related]  

  • 59. Efficacy of trichloroacetic acid (95%) in the management of xanthelasma palpebrarum.
    Cannon PS; Ajit R; Leatherbarrow B
    Clin Exp Dermatol; 2010 Dec; 35(8):845-8. PubMed ID: 20456397
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Gastric xanthelasma and metabolic disorders: A large retrospective study among Chinese population.
    Chen Y; He XJ; Zhou MJ; Li YM
    World J Gastroenterol; 2017 Nov; 23(43):7756-7764. PubMed ID: 29209116
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.